Fibrogen Announces Passing of CEO Thomas B. Neff, Scientific Innovator and Pioneering Biopharmaceutical Executive
SAN FRANCISCO, Aug. 26, 2019 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) announced today that Thomas B. Neff, Chief Executive Officer and Chairman of the Board of Directors of FibroGen, passed away unexpectedly this past weekend. Board member James A. Schoeneck has been named FibroGen’s Interim CEO.
Name: Thomas B. Neff
Country: USA
Company: FibroGen, Inc.
Branch: Pharma
Position: CEO & Chairman
Reason: Dead
Announcement Date: August 25, 2019, 10:00pm